Mach7 wins US AMRADNET deal worth A$1.7M, 5-year ARR; deployment cut to 45 days, signaling accelerated growth ...
OncoSil Medical wins TGA approval for OncoSil device to treat unresectable LAPC; ARTG-listed, enabling Australian launch as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results